ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 45 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $8,624,000 | -54.3% | 2,024,400 | -43.0% | 0.15% | -54.0% |
| Q1 2021 | $18,851,000 | -1.5% | 3,550,000 | 0.0% | 0.33% | -1.2% |
| Q4 2020 | $19,135,000 | -78.2% | 3,550,000 | -67.7% | 0.33% | -73.5% |
| Q3 2020 | $87,780,000 | -12.4% | 11,000,000 | +7.8% | 1.25% | -37.0% |
| Q2 2020 | $100,170,000 | +2871.5% | 10,200,000 | +5446.5% | 1.98% | +113.4% |
| Q2 2015 | $3,371,000 | – | 183,900 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $5,165,000 | 4.93% |
| Long Focus Capital Management, LLC | 4,429,491 | $9,125,000 | 1.17% |
| Endurant Capital Management LP | 2,160,890 | $4,451,000 | 1.17% |
| NEA Management Company, LLC | 17,082,611 | $35,190,000 | 1.02% |
| Matrix Capital Management Company, LP | 38,974,185 | $80,287,000 | 0.96% |
| Key Client Fiduciary Advisors, LLC | 420,447 | $866,000 | 0.68% |
| ACT CAPITAL MANAGEMENT, LLC | 90,000 | $185,000 | 0.20% |
| DAFNA Capital Management LLC | 351,064 | $723,000 | 0.19% |
| PFM Health Sciences, LP | 2,374,674 | $4,892,000 | 0.18% |
| Rock Springs Capital Management LP | 2,297,194 | $4,732,000 | 0.12% |